| pubmed-article:18635842 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C0917798 | lld:lifeskim |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C0332306 | lld:lifeskim |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:18635842 | lifeskim:mentions | umls-concept:C0908244 | lld:lifeskim |
| pubmed-article:18635842 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:18635842 | pubmed:dateCreated | 2008-9-30 | lld:pubmed |
| pubmed-article:18635842 | pubmed:abstractText | The neutral results of the SAINT II trial have again highlighted difficulties translating neuroprotective efficacy from bench to bedside. Animal studies are susceptible to study quality biases, which may lead to overstatement of efficacy. We report the impact of study quality on published estimates of the efficacy of NXY-059 in animal models of stroke. | lld:pubmed |
| pubmed-article:18635842 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635842 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18635842 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635842 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18635842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635842 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18635842 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:18635842 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:18635842 | pubmed:author | pubmed-author:DonnanGeoffre... | lld:pubmed |
| pubmed-article:18635842 | pubmed:author | pubmed-author:DirnaglUlrich... | lld:pubmed |
| pubmed-article:18635842 | pubmed:author | pubmed-author:HowellsDavid... | lld:pubmed |
| pubmed-article:18635842 | pubmed:author | pubmed-author:MacleodMalcol... | lld:pubmed |
| pubmed-article:18635842 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:18635842 | pubmed:author | pubmed-author:SenaEmily SES | lld:pubmed |
| pubmed-article:18635842 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18635842 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:18635842 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18635842 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18635842 | pubmed:pagination | 2824-9 | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:meshHeading | pubmed-meshheading:18635842... | lld:pubmed |
| pubmed-article:18635842 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18635842 | pubmed:articleTitle | Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. | lld:pubmed |
| pubmed-article:18635842 | pubmed:affiliation | Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK. malcolm.macleod@ed.ac.uk | lld:pubmed |
| pubmed-article:18635842 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18635842 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18635842 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635842 | lld:pubmed |
